TipRanks

Richard Barry Insider Profile

32 Followers
Richard Barry, President & CEO, Director at Filana Therapeutics, holds 1.34M shares in Filana Therapeutics (Ticker: FLNA), holds 3.23M shares in Sarepta Therapeutics (Ticker: SRPT), holds 3.34M shares in MiMedx Group (Ticker: MDXG). Most recently, Richard Barry Bought ― shares of Filana Therapeutics on Oct 01, 2026 for an estimated value of $278.13K.
tipranks
Richard Barry

Richard Barry
Filana Therapeutics (FLNA)
President & CEO, Director

Ranked #19,224 out of 109,287 Corporate Insiders

Profitable Transactions

56%
9 out of 16 Profitable Transactions

Average Return

+6.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$75M
81.48%
17.37%
1.16%
A breakdown of Richard Barry's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
Director
MiMedx Group
(MDXG)
Director
Filana Therapeutics
(FLNA)
President & CEO, Director
Roles that Richard Barry holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Buy
Date:Mar 16, 2016 - Mar 16, 2017
Return:+108.50%
The most profitable trade made by Richard Barry

Richard Barry's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Filana Therapeutics
Oct 01, 2026
President & CEO, Director
Informative Buy
278.13K
$867.00K
Sarepta Therapeutics
Jun 05, 2026
Director
Uninformative Buy
―
$61.08M
MiMedx Group
Aug 06, 2020
Director
Uninformative Buy
―
$13.02M
List of latest transactions for each holding click on a transaction to see Richard Barry's performance on stock

Richard Barry insider profile FAQ

What is the percentage of profitable transactions made by Richard Barry?
The percentage of profitable transactions made by Richard Barry is 56%.
    What is the average return per transaction made by Richard Barry?
    The average return per transaction made by Richard Barry is 6.50%.
      What stocks does Richard Barry hold?
      Richard Barry holds: FLNA, SRPT, MDXG stocks.
        What was Richard Barry’s latest transaction?
        Richard Barry latest transaction was an Informative Buy of $278.13K.
          What was Richard Barry's most profitable transaction?
          Richard Barry’s most profitable transaction was an Informative Buy of SRPT stock on March 16, 2016. The return on the trade was 108.50%.
            What is Richard Barry's role in Filana Therapeutics?
            Richard Barry's role in Filana Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.